The department supports investigator-led research through a series of well-founded laboratories. This research covers every aspect of biological science related to medicine: from the bench to the bedside, from blue sky to full clinical trials, from technology development to spin-out. It covers many fields and many clinical disciplines.
The department supports this research in an environment designed to foster the long-term career development of fellows and research staff.
All of the above is made possible through the generosity and long-term support of our sponsors and funders.
United Nations sustainable development goals aim for the elimination of viral hepatitis as a public health threat by 2030, leading to efforts to upscale the availability and accessibility of hepatitis B virus (HBV) vaccination, diagnosis, and treatment globally. However, a variety of societal factors, including beliefs, traditions, and stigma, can be a major obstacle to all of these interventions. Philippa Matthews and co-researchers set out to investigate how HBV is understood and described in communities in Uganda, and whether there is evidence of potential stigma.
Dr Timothy Hinks, from NDM'S Experimental Medicine Division led one of two research groups studying these cells. The research was also supported by the NIHR Oxford Biomedical Research Centre. These cells could be harnessed to help heal tissues and treat diseases such as infections of the lung, the bowel or the skin. Dr Hinks said: MAIT cells are remarkable in several ways. They are very numerous throughout the different tissues of our bodies. They are also ancient in evolutionary terms, being found in animals as distantly related as humans, mice and even opossums and Tasmanian devils.